4.6 Article

A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas

Related references

Note: Only part of the references are listed.
Article Immunology

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer

Zhiwei Wu et al.

Summary: A 4-FRL signature was identified as a promising biomarker for predicting clinical outcomes and therapeutic responses in colon cancer patients. The signature exhibited a stronger predictive power for survival compared to traditional clinicopathological features. Additionally, the signature was associated with immune landscape, somatic mutation, and drug sensitivity.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Comprehensive Analysis of Pyroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients with Colon Cancer

Li Liu et al.

Summary: This study found that pyroptosis-related lncRNAs are differentially expressed in colorectal cancer and are associated with patient prognosis and immune characteristics.

JOURNAL OF ONCOLOGY (2022)

Article Genetics & Heredity

Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma

Guangzhen Qu et al.

Summary: A prognostic risk model composed of seven pyroptosis-related lncRNAs was established in this study, which showed excellent accuracy in predicting overall survival of HCC patients. The high-risk group exhibited tumor characteristics associated with progression, and gene set enrichment analysis revealed enrichment of cell cycle and focal adhesion pathways.

FRONTIERS IN GENETICS (2022)

Article Oncology

miR-497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR-588/TUSC1 axis

Li-Ya Ji et al.

Summary: MicroRNA (miR)-497 and its host gene MIR497HG play important roles in tumorigenesis, cancer progression, and chemotherapy resistance in glioma. Low expression levels of miR-497 or MIR497HG are associated with poor prognosis in glioma patients, while overexpression inhibits proliferation and cell cycle progression of glioma cells. They function by directly targeting cyclin E1 and miR-588/tumor suppressor candidate 1.

ONCOLOGY REPORTS (2021)

Article Cell Biology

Gene expression profiles for an immunoscore model in bone and soft tissue sarcoma

Jingyuan Fan et al.

Summary: This study analyzed data from 334 samples with 8 tumor types, clustering patients into three subgroups based on immune composition. The research revealed that immune fractions have a significant impact on the prognosis of sarcoma patients, with the proposed immunoscore showing promise for survival prediction.

AGING-US (2021)

Article Genetics & Heredity

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma

Lin Qi et al.

Summary: Soft tissue sarcoma (STS) is a rare and diverse group of malignancies that presents significant therapeutic challenges. This study identified aberrantly expressed pyroptosis-related genes (PRGs) in STS and constructed a gene signature associated with prognosis. High pyroptosis-related risk scores were linked to poorer prognosis in STS patients, indicating potential clinical significance.

FRONTIERS IN GENETICS (2021)

Article Oncology

Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer

Zirui Zhao et al.

Summary: This study constructed a model with necroptosis-related lncRNAs to predict prognosis and aid in precision medication for gastric cancer patients. Analysis of IC50 differences between risk groups and clustering helped effectively distinguish between cold and hot tumors, contributing to precise mediation.

JOURNAL OF ONCOLOGY (2021)

Article Oncology

Prognostic Value of a Pyroptosis-Related Long Noncoding RNA Signature Associated with Osteosarcoma Microenvironment

Xinxin Bu et al.

Summary: The research identified potential biomarkers associated with osteosarcoma prognosis and confirmed their effectiveness in predicting patient outcomes. By analyzing RNA data and clinical information, researchers found that high-risk lncRNAs performed well in predicting survival rates for osteosarcoma.

JOURNAL OF ONCOLOGY (2021)

Review Oncology

Primary Intracranial Leiomyosarcoma Secondary to Glioblastoma: Case Report and Literature Review

Liyan Zhao et al.

Summary: Leiomyosarcoma, especially primary intracranial leiomyosarcoma (PILMS), is rare and poorly researched. This study presents a case of PILMS secondary to glioblastoma, highlighting the importance of aggressive multimodal treatment with surgery and radiotherapy for PILMS. Further research, including systemic treatment options, is needed to address the unanswered questions surrounding PILMS.

FRONTIERS IN ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma

Yuan Yang et al.

Summary: This study constructed a risk model based on five-gene signature by identifying angiogenesis-related immune genes affecting the prognosis of HCC. The model effectively predicted the survival outcome of HCC patients and showed promising clinical prediction value.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemistry & Molecular Biology

Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma

Yun Tang et al.

Summary: In this study, a prognostic multilncRNA signature based on ferroptosis-related differentially expressed lncRNAs in HNSCC was constructed and found to impact the prognosis of HNSCC, outperforming traditional clinicopathological features in predicting HNSCC prognosis. The signature was associated with poor prognosis of HNSCC, with a higher AUC value. GSEA identified immune and tumor-related pathways affected by the signature, while TCGA revealed significant differences in T cell functions and immune checkpoint expression between low-risk and high-risk groups.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

PLA2G10 facilitates the cell-cycle progression of soft tissue leiomyosarcoma cells at least by elevating cyclin E1/CDK2 expression

Gang Tan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Medicine, Research & Experimental

Comprehensive profiling of immune-related genes in soft tissue sarcoma patients

Chuan Hu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Article Multidisciplinary Sciences

The GTEx Consortium atlas of genetic regulatory effects across human tissues

Francois Aguet et al.

SCIENCE (2020)

Article Oncology

Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea

Hyo Song Kim et al.

CANCER RESEARCH AND TREATMENT (2019)

Article Medicine, Research & Experimental

LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma

Shengnai Zheng et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Cardiac & Cardiovascular Systems

Basic Knowledge in Soft Tissue Sarcoma

Kevin Bourcier et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2019)

Article Pathology

Diversity, Mechanisms, and Significance of Macrophage Plasticity

Massimo Locati et al.

Annual Review of Pathology-Mechanisms of Disease (2019)

Review Pharmacology & Pharmacy

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Marco Tagliamento et al.

EXPERT OPINION ON PHARMACOTHERAPY (2018)

Review Pharmacology & Pharmacy

Erlotinib for the treatment of brain metastases in non-small cell lung cancer

Jeffrey V. Brower et al.

EXPERT OPINION ON PHARMACOTHERAPY (2016)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article

Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge

Katarzyna Tomczak et al.

Wspolczesna Onkologia-Contemporary Oncology (2015)

Article Biochemistry & Molecular Biology

The UCSC Cancer Genomics Browser: update 2015

Mary Goldman et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Physiology

Necroptosis: is there a role for mitochondria?

Kurt D. Marshall et al.

FRONTIERS IN PHYSIOLOGY (2014)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Review Pathology

Cancer immunoediting and spontaneous tumor regression

Neel Sengupta et al.

PATHOLOGY RESEARCH AND PRACTICE (2010)

Article Urology & Nephrology

Adult genitourinary sarcoma: The 25-year memorial Sloan-Kettering experience

Zohar A. Dotan et al.

JOURNAL OF UROLOGY (2006)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

A Degterev et al.

NATURE CHEMICAL BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Cytoscape: A software environment for integrated models of biomolecular interaction networks

P Shannon et al.

GENOME RESEARCH (2003)